Schirmacher P, Held W A, Yang D, Biempica L, Rogler C E
Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.
Am J Pathol. 1991 Jul;139(1):231-41.
In a major urinary protein (MUP)-promoter/simian virus 40 (SV40)Tag transgenic mouse line (MT-D2) the liver-directed, androgen-regulated transgene expression leads to synchronized pathology resulting in a stepwise progression to multiple hepatocellular carcinomas. SV40Tag-activated replication gives rise to two different preneoplastic alterations in hepatocytes, which are characterized in detail: 1) dysplasia and finally cell death in the original hepatocyte population and 2) amplification of periportal transitional hepatocytes leading to multifocal hyperplasia and hepatocellular carcinoma. Multifocal hyperplasia, most probably the equivalent of SV40Tag-immortalization, grows confluent and leads to hepatomegaly. SV40Tag-independent, secondary events are necessary for the tumor development from confluent hyperplasia. This allows further investigation of the steps involved in malignant transformation and progression during hepatocarcinogenesis in vivo.
在一个主要尿蛋白(MUP)启动子/猿猴病毒40(SV40)大T抗原转基因小鼠品系(MT-D2)中,肝脏定向、雄激素调节的转基因表达导致同步病理变化,逐步发展为多发性肝细胞癌。SV40大T抗原激活的复制在肝细胞中产生两种不同的癌前改变,具体特征如下:1)原代肝细胞群体发育异常并最终细胞死亡;2)门静脉周围过渡性肝细胞扩增,导致多灶性增生和肝细胞癌。多灶性增生很可能相当于SV40大T抗原永生化,融合生长并导致肝肿大。从融合性增生发展为肿瘤需要不依赖SV40大T抗原的继发性事件。这使得在体内肝癌发生过程中对恶性转化和进展所涉及的步骤进行进一步研究成为可能。